Northwestern Medicine

Nov. 9, 2011 Declared Steven T. Rosen Day in Chicago

Northwestern Memorial Hospital November 08, 2011

Mayor Emanuel honors Northwestern Medicine physician for strides and commitment to cancer research

CHICAGO, IL – Steven T. Rosen, MD, FACP, director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital, is being honored by the Israel Cancer Research Fund (ICRF) for his contributions toward the fight against cancer. Rosen, a well-known and longtime oncologist at Northwestern Memorial Hospital, will be recognized at the organization’s annual Todah Rabah Gala today, Nov. 9.

“I’m truly humbled by the recognition, as I have been privileged to care for remarkable individuals and blessed to work alongside phenomenal colleagues and staff,” said Rosen, who also is the Genevieve Teuton Professor of Medicine at Northwestern University Feinberg School of Medicine. “I went into medicine to help combat this dreadful disease. My research is an extension of ways that I can make a difference for patients—potentially now and in the future. I’m grateful to Mayor Emanuel and ICRF for this great honor.”

Rosen’s world-renowned work in cancer research and treatment spans more than 30 years. He is acknowledged as one the nation’s Top Doctors by Castle Connolly and named in the annual Best Doctors in America® list.

“We are ecstatic about paying tribute to one of today’s finest advocates in the fight against cancer,” said Ken Goodman, ICRF Chairman of the Board and Presiding Director of Forest Laboratories. “Dr. Rosen is tireless in his mission and he has been an outstanding ambassador for ICRF. We are proud of his exceptional contributions to the oncology field and are honored to call him a friend.”

“Dr. Rosen’s commitment to his patients is unwavering,” said Dean M. Harrison, president and CEO, Northwestern Memorial HealthCare, parent to Northwestern Memorial Hospital. “We congratulate him for years of clinical care and cancer research that have made a difference in the lives of so many patients.”

Rosen's laboratory research focuses on experimental therapeutics and hematologic malignancies. He has published more than 250 scientific papers. Rosen serves on the advisory boards of several NCI-designated Cancer Centers, the Leukemia and Lymphoma Society of America, the Multiple Myeloma Research Foundation, the Lymphoma Research Foundation and the Wendy Will Cancer Research Foundation. He has also served as an advisor to Great Britain's Cancer Research Campaign.

Media Contact

Media Relations